Longevity.Technology UNLOCKED

About Longevity.Technology UNLOCKED

Longevity.Technology UNLOCKED brings together science, business, and human potential to explore the frontier of longer, healthier living. 🎙 Mondays: In-depth conversations with scientists, founders, investors, operators, and elite performers shaping the longevity ecosystem. 🧠 Fridays: A sharp weekly round-up of the biggest stories, trends, and insights from across the longevity space. If you’re curious about the future of health, performance, and lifespan, this is where it gets UNLOCKED.

Publisher

Longevity.Technology

Category

health & fitness

Language

en

Explicit

No

First episode

2 Jan 2026

Latest episode

26 Oct 2026

Latest episodes

79 episodes in the feed.

1. 

   26 Oct 2026

   Why The $101 Million XPRIZE Could Redefine Human Healthspan

   Guest: Jamie Justice, Ph.D. Executive Director, XPRIZE Healthspan and Vice President of the Health Domain at XPRIZE Foundation LinkedIn: https://www.linkedin.com/in/jamie-justice-ph-d-6b933146/ (https://www.linkedin.com/in/jamie-justice-ph-d-6b933146/) Website: https://www.xprize.org/ (https://www.xprize.org/) Steven R. Cummings, MD Executive Director at S.F. Coordinating Center (SFCC) in the CPMC Research Institute LinkedIn: https://www.linkedin.com/in/steve-cummings-71668514a/ (https://www.linkedin.com/in/steve-cummings-71668514a/) Website: https://www.xprize.org/people/steve-cummings (https://www.xprize.org/people/steve-cummings) _______________ What if the breakthrough longevity needs isn’t another intervention, but a better way to prove what works? Phil Newman sits down with XPRIZE Healthspan director Jamie Justice and judging chair Professor Steven Cummings to explore the $101 million competition. Together they explain why muscle, cognitive and immune function form its evidence framework, and how one-year trials could help model longer-term healthspan gains. From repurposed drugs to gene therapies, finalists must demonstrate measurable effects under common standards. They also discuss FDA pathways, scalability, safety and prevention versus reversal. In this episode, you'll learn: - How finalists are judged - Why function matters beyond biomarkers - How trials model 10–20 years of decline - Why scalability matters - Why safety could determine success If you want to understand how longevity interventions could become credible medicine, this episode connects rigorous trials with real-world healthspan. Subscribe for weekly episodes that explore longevity science, preventative medicine, and the systems shaping how we live longer and better. _______________ Host: Phil Newman: https://qrco.de/bgXpNY (https://qrco.de/bgXpNY)

2. 

   19 Oct 2026

   Could Intrinsic Capacity Become the Endpoint for Longevity Drugs?

   Sponsor: Sooo.me (Sooo.me) Sooo.me™ is a longevity-focused nutraceutical brand offering science-backed supplements designed to support healthy aging, energy, focus, cellular health, and overall wellbeing. Its range combines high-purity ingredients, medicinal mushroom extracts, and targeted formulations with an emphasis on quality, transparency, and sustainable packaging. See what it can do for you — click below to try it today and use code LONGEVITYTECHNO for 10% off. Link: https://sooo.me/?ref=LTUNLOCKED (https://sooo.me/?ref=LTUNLOCKED) ---------- Guests: John Beard Irene Diamond Professor and Director International Longevity Center USA, Columbia University LinkedIn: https://www.linkedin.com/in/john-beard-987b801b/ (https://www.linkedin.com/in/john-beard-987b801b/) Website: https://www.publichealth.columbia.edu/profile/john-beard-mbbs (https://aging.columbia.edu/about/people/Beard) ---------- What if the way we measure health is holding back the science of aging? Phil Newman sits down with Dr. John Beard, Irene Diamond Professor and Director of the International Longevity Centre USA at Columbia University, to explore intrinsic capacity – measuring health through what people can actually be and do rather than the diseases they have. Together they unpack the five domains of intrinsic capacity and why functional measures could give researchers a more continuous picture of aging. From simple chair-rise and hearing tests to clinical trial endpoints, biomarkers and wearables, Beard explains both the potential and the gaps that remain. They also discuss why “70 is the new 60,” the difference between prevention and health promotion, why some longevity clinics are ahead of the evidence, and how intrinsic capacity could reshape healthcare funding and drug development. In this episode, you'll learn: - Why disease alone is an incomplete measure of aging - How intrinsic capacity measures cognitive, locomotive, psychological, sensory and vitality domains - Why better standardized measures could help shorten aging intervention trials - How early-life health can influence capacity decades later - Why healthcare systems could eventually reward improvements in health rather than throughput If you want to understand how measuring function could change geroscience, clinical trials and healthcare itself, this episode connects aging biology with practical measures of how well people actually live. Subscribe for weekly episodes that explore longevity science, preventative medicine, and the systems shaping how we live longer and better. ---------- Host: Phil Newman: https://qrco.de/bgXpNY (https://qrco.de/bgXpNY)

3. 

   5 Oct 2026

   BPC-157, GLP-1s and the New Peptide Gold Rush

   Phil Newman interviews Dr. Fady Hannah-Shmouni and Koehl Robinson about the rapidly evolving peptide therapy market, separating hype from evidence.

Who has been a guest on Longevity.Technology UNLOCKED

Names identified in recent episode analyses. Showing up to five guests.

• Fady Hannah-Shmouni
• Koehl Robinson
• Dr Christopher Shade
• Elizabeth Poynor
• David Dodick

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

4 ratings

Spotify

5.0 / 5

6 ratings

Contact Longevity.Technology UNLOCKED

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Shows with a similar audience

• 

  Biohacking Superhuman Performance

• 

  The Human Upgrade with Dave Asprey

• 

  Ben Greenfield Life

• 

  The Energy Blueprint Podcast

• 

  The Peter Attia Drive

• 

  FoundMyFitness

Questions about Longevity.Technology UNLOCKED